Andrew Satlin - Net Worth and Insider Trading
Andrew Satlin Net Worth
The estimated net worth of Andrew Satlin is at least $748,988 dollars as of 2024-05-16. Andrew Satlin is the EVP and Chief Medical Officer of Intra-Cellular Therapies Inc and owns about 11,338 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $748,988. Details can be seen in Andrew Satlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Satlin has not made any transactions after 2020-01-09 and currently still holds the listed stock(s).
Transaction Summary of Andrew Satlin
Andrew Satlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Satlin owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .
Click here to see the complete history of Andrew Satlin’s form 4 insider trades.
Insider Ownership Summary of Andrew Satlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2020-01-09 | EVP and Chief Medical Officer |
Andrew Satlin Latest Holdings Summary
Andrew Satlin currently owns a total of 1 stock. Andrew Satlin owns 11,338 shares of Intra-Cellular Therapies Inc (ITCI) as of January 9, 2020, with a value of $748,988.
Latest Holdings of Andrew Satlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2020-01-09 | 11,338 | 66.06 | 748,988 |
Holding Weightings of Andrew Satlin
Andrew Satlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Satlin has made a total of 1 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 11,573 shares on January 9, 2020, which brought Andrew Satlin around $302,750.
Insider Trading History of Andrew Satlin
- 1
Andrew Satlin Trading Performance
Andrew Satlin Ownership Network
Andrew Satlin Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Andrew Satlin is the EVP and Chief Medical Officer of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include Chief Medical Officer Suresh K. Durgam , EVP & Chief Commercial Officer Mark Neumann , and VP of Finance & CFO & Secretary Lawrence J. Hineline .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Andrew Satlin made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 181,034 shares made by Mark Neumann , a net sale of 554,970 shares made by Sharon Mates , and a net sale of 233,341 shares made by Michael Halstead .
In summary, during the past 3 months, insiders sold 237,827 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 237,827 shares. During the past 18 months, 1,382,842 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,382,842 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Andrew Satlin Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Satlin. You might contact Andrew Satlin via mailing address: C/o Intra-cellular Therapies, Inc., 430 East 29th Street, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
